How Can We Engineer CAR T Cells to Overcome Resistance?
Maya Glover,1 Stephanie Avraamides,2 John Maher1– 4 1Leucid Bio Ltd., Guy’s Hospital, London, SE1 9RT, UK; 2King’s College London, School of Cancer and Pharmaceutical Sciences, Guy’s Hospital, London, SE1 9RT, UK; 3Department of Clinical Immunology and Allergy...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/83cff87a5797459291983d07914ea971 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|